FREDERIC ALARCON: Open Payments
NPI 1407441975 · LAIE, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 12 payments from 5 companies in 2025. Trend: 2023 $120 · 2024 $378 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $158 |
| Neurocrine BioSciences, Inc. | 1 | $102 |
| Alkermes, Inc. | 4 | $89 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: VRAYLAR, INGREZZA, ARISTADA, UZEDY, CAPLYTA.
Industry payments across HI — which companies pay providers there.
